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Table 1:   Sample characteristics
Intensive insulin therapy requires the ability of correct bolus calculation and carbo-
hydrate estimation. In order to calculate the correct prandial insulin dose, several 
factors have to be considered like current glucose level, amount of planned car-
bohydrate intake, physical activity, and circadian fluctuation of insulin sensitivity. 
Interestingly, as recent meta-analyses demonstrated, training in carbohydrate coun-
ting had no effect on glycaemic control. However, there is no assessment tool that 
simultaneously assesses and therefore disentangles the ability of bolus calcu- 
lation and carbohydrate estimation. The objective of this study was the development 
and psychometric evaluation of an assessment tool for carbohydrate estimation and 
bolus calculation (called SMART). Of special interest were the associations of both 
abilities with glycaemic control.
B A C K G R O U N D & A I M S
C O N C L U S I O N
R E S U L T S
M E T H O D SM A T E R I A L S & M E T H O D S
The SMART tool consists of one scale for the assessment of bolus calculation (BOLUS) 
with 10 items and a scale for carbohydrate estimation (CARB) with 12 items.
• BOLUS scale: patients were confronted with different treatment situations in 
which they had to decide upon their dosage of bolus insulin. Patients were asked 
to select the correct insulin dose out of 5 predefined choices.
•  CARB scale: photographs depicting food portions or complex meals were used. 
Patients were asked to select the correct carbohydrate amount out of 4 predefi-
ned choices.
Inpatients with type 1 or type 2 diabetes on an intensive insulin regimen were invited 
to participate. HbA1c and stored data of patients’ blood glucose meters were used to 
determine glycaemic control.
411 patients participated (age: 42.9 ± 15.7 years; 48 % female; HbA1c: 8.6 ± 1.8%; 
28 % with CSII treatment; see table 1) and approximately 56,000 blood glucose meter 
ratings could be obtained. 
Reliability of SMART:
• The 10 items of the BOLUS scale achieved an internal consistency (Cronbach‘s 
alpha) of 0.78 with a mean item-selectivity of rit = 0.46 and a mean difficulty of 
66% correct answers (mean score = 6.6 ± 2.6).
• The 12 items of the CARB scale achieved an internal consistency (Cronbach‘s 
alpha) of 0.67 with a mean item selectivity of rit = 0.31 and a mean difficulty of 
60% correct answers (mean score = 7.2 ± 2.5). 
Validity – group differences (see figure 1):
• Diabetes Type: Patients with type 1 diabetes were significantly better on both 
scales than patients with type 2 diabetes (BOLUS: Cohen’s d = 0.5; CARB: Cohen’s 
d = 0.9)
• Therapy: Patients with an insulin pump (CSII) were better on both scales than 
patients with multiple daily insulin injections (MDI) (BOLUS: Cohen’s d = 0.3; CARB: 
Cohen’s d = 0.3)
• Diabetes education: Patients with previous diabetes education performed signi-
ficantly better on both scales (BOLUS: Cohen’s d = 0.4; CARB: Cohen’s d = 0.4)
Additionally, better bolus calculation was associated with a higher level of education 
SMART is a reliable and valid tool to assess patients’ abilities to calculate their insulin 
dose and to estimate their carbohydrate content. SMART is also sensitive to depict 
effects of diabetes education and of CSII treatment in comparison to multiple daily 
insulin injections. Furthermore, SMART differentiated patients who are on an inten-
sive insulin regimen since diagnosis (type 1 patients) from patients who started with 
the intensive insulin regimen later on (type 2 patients).
This study also demonstrates that both abilities have substantial associations with 
glycaemic control. While bolus calculation seems to be more influential for HbA1c and 
fluctuation of blood glucose, carbohydrate estimation is more important for keeping 
blood glucose in a euglycaemic range.
However, there are some limitations which should be considered. First of all, not 
every patient’s blood glucose meter could be analysed. This was mostly due to tech-
nical difficulties when trying to readout stored blood glucose data from different 
(sometimes outdated) blood glucose meters and the unwillingness of patients to hand 
over their meters. Secondly, relatively few type 2 diabetes patients could be included. 
In summary, the SMART-tool is a brief assessment tool which can assist the identi-
fication of people with diabetes on an intensive insulin regimen, who are in need 
for improvements in carbohydrate estimation and/or calculation of prandial insulin 
doses. It can also be used in further research to investigate the effect of training in 
bolus calculation and carbohydrate estimation on glycaemic control.
Figure 3:  Association of bolus calculation and 
the standard deviation of  
blood glucose values.
Figure 1:  Group differences
Figure 2: Association of bolus calculation 
and HbA1c.
Figure 4:  Association of carbohydrate  
estimation and the frequency of 
severe hyperglycaemia.
(r = 0.24, p < .05) and better carbohydrate estimation was associated with a lower 
body mass index (r = -0.2, p < .05).
Validity – Associations with glycaemic control (see table 2):
• Better bolus calculation was associated with a lower HbA1c (r = -0.27, p < .01; 
figure 2), lower mean blood glucose (r = -0.29, p < .01), and a lower standard 
deviation of blood glucose values (r = -0.43, p < .01; figure 3). 
• Better carbohydrate estimation was associated with a lower mean blood glucose 
(r = -0.3, p < .01), a lower frequency of severe hyperglycaemia (r = -0.27, p < .01; 
figure 4), and a higher frequency of euglycaemia (r = 0.26, p < .01; figure 5).
Table 2:  Associations with glycaemic control
Figure 5:  Association of carbohydrate  
estimation and the frequency of 
euglycaemia.
